Objective: Aim of this study was to analyze whether children with objectively measured second-hand cigarette smoke (SHS) exposure suffer from a more severe course of disease when hospitalized with lower respiratory tract infection (LRTI) due to respiratory syncytial virus (RSV).
| INTRODUCTION
Second-hand cigarette smoke (SHS) is a prevalent and dominant indoor air pollutant that has major effects on the health of children. It is estimated, that 40-50% of children worldwide are regularly exposed to SHS, primarily by being around smoking parents and/or other household members. 1, 2 Nicotine is distilled from burning tobacco, carried on tar droplets and inhaled both by active smokers, but also by children being around smokers. 3, 4 Apart from this type of uptake, nicotine is also ingested as residual tobacco smoke pollutant remaining on surfaces and in dust via inhalation, ingestion, or dermal contact referred to as third hand smoke. 5 Children living in homes with self-reported smokers have more severe respiratory illnesses than those living in homes with no smokers, and infants and children exposed to SHS have more cough, wheeze and mucous production. [6] [7] [8] [9] Recently, elevated hair nicotine values in infancy were found to be risk factor for wheezing and asthma in children. 10 Nicotine is extensively metabolized, primarily in the liver, and its major proximate metabolite is cotinine in plasma. 7, 11 Urinary cotinine concentrations are on average four-to five-fold higher than in plasma, making urine a more sensitive medium for the detection of low-level exposure to tobacco smoke like SHS. 12 Liquid chromatography tandem mass spectography is the gold-standard in measuring the urinary cotinine levels. 13 Human respiratory syncytial virus (RSV) is the most common cause of acute respiratory tract infection in infants, 14 occurring in 50% of children during the 1st year of life. 15 Severity of disease ranges from rhinitis to severe lower respiratory tract infection (LRTI), requiring intensive care treatment. LRTI caused by RSV infection leads to hospitalization in between 1% and 2.5% of all infants 16, 17 and 66 000-199 000 deaths per year may be linked to RSV infection worldwide. 18 A recent study has shown that diagnostic and therapeutic measures for RSV LRTI vary widely between different countries and hospital sites. 19 There is growing evidence that SHS exposure may increase disease severity of RSV-associated airway infections. 16, [20] [21] [22] [23] First, a higher rate of hospital admission for RSV-associated LRTI has been found in children who were reported to have been exposed to second-hand smoke. 9, [21] [22] [23] Second, data published by Bradley et al 20 indicate that infants with RSV infection exposed to SHS at home, again assessed by a subjective method of self-report of caretakers, have a significantly lower oxygen-saturation (SpO 2 ) during hospitalization than those not exposed. Finally, Semple et al 16 showed that children, who had a reported history of exposure to SHS, more frequently need supplemental oxygen and mechanical ventilation.
Aim of this study was to analyze for the first time using objective markers of SHS exposure via urine cotinine levels on admission, whether children admitted to hospital due to RSV LRTI have lower oxygen saturation on admission and a more severe course of disease after being recently exposed to nicotine. With regards to measuring disease severity objectively, Bamberger et al 24 already described a score, which has been shown to be useful to grade disease severity in patients with RSV: the "admission clinical severity score" (CSSA) ( Table 1 ). The CSSA score is a non-validated commonly used clinical scoring system designed for assessing the severity of RSV infection on admission into the hospital. Scoring was performed by the pediatrician in charge in the outpatient clinic.
| MATERIALS AND METHODS
Decisions were made by one doctor only. All doctors were trained regarding study participation, including relevant in-and exclusion criteria, informed consent, physical examination, and for completion the clinical scores.
Parents/caregivers were asked to complete a customized questionnaire including information on demographic factors such as apartment size, number of siblings, family history of asthma or other lung diseases, and known risk factors for severe RSV infection such as prematurity and concomitant diseases, furthermore birth weight and age-adjusted weight and detailed information on parental smoking (Table 2 ). We defined the exposure level of reported second hand smoke (based on the questionnaire) as follows: (1) A urine sample was collected, and cotinine was measured using chromatography tandem mass spectography. Using an API 4000
LC-MS/MS System (Sciex, Inc., Toronto, Canada) as described previously. 25 Standards and calibrators were obtained from Recipe (RECIPE Chemicals + Instruments GmbH, Munich, Germany). Urinary cotinine half-life has been reported to be 6-22 h, 26, 27 which makes cotinine a reliable indicator for recent SHS exposure within a maximum of 1 day.
Urinary cotinine values were recorded as the objective marker for SHS and the lower limit of detection (7 μg/L) was used as a threshold.
Values above detection limit were defined as positive samples (COT+)
because the presence of cotinine in urine was proven. Urinary cotinine can only be a result of the child's exposure to nicotine, and irrespective of whether nicotine entered the body by inhalation or by direct resorption through the skin, 3 
| RESULTS
During a period of two RSV seasons between 2015 and 2017, a total of 217 patients were enrolled, out of which 32 patients (14.7%) had to be excluded ( Figure 1 ).
Hence, data of 185 children were included into the analyses.
Mean (standard deviation [SD]) age of the study population was 106 days (±80) with a male: female ratio of 53%:47%. For 10 patients, questionnaire data on SHS were missing. First, concerning Cotinine could be identified as the only predictor for SpO 2 in this model (P < 0.001).
Twenty-five (13.5%) patients were found to be "cotinine positive"
(COT+) defined as a urinary cotinine level of ≥7 μg/L on admission.
COT+ patients had significantly lower birthweight (3186.9 g; ±517.2) than COT− patients (3456.2 g; ±589.2; P < 0.05). Demographic characteristics for "cotinine positive" (COT+) and "cotinine negative"
(COT−) patients were similar (Table 3) . Mean (SD) SpO 2 on admission for COT+ and COT− children was 94.8% (±2.0) and 96.8% (±3.0), respectively (P < 0.001) (Figure 2 ).
Mean CSSA score for COT+ and COT− patients was 2.56 (±2.22) versus 1.71 (±1.71), respectively (P < 0.05) (Figure 3 ).
Most patients needing supplemental oxygen on admission (defined as patients with a SpO 2 <92%) were actually found within the COT+ patient group (28% for COT+ compared to 4% for COT−; c 2 (3175) = 19.25, P < 0.01).
As defined prior to study start, all children were divided into exposure groups according to the reported SHS exposure assessed by questionnaire. Hence, a total of 175 patients were divided into three groups according to their SHS exposure status: no reported exposure "no SHS" (group 0; n = 82), "low level SHS" (group 1; n = 41), and "high level SHS" (group 2; n = 27) ( Table 2) . With regards to a potential correlation between cotinine status and the questionnaire response concerning smoking-described using the allocated SHS group-there were statistically significantly more COT + patients in the high-level SHS group 2 (c 2 (3175) = 26.57, P < 0.001). However, in the group of patients without a reported history of SHS exposure (SHS 0 group), 3 (12%) infants were found to actually be COT+ patients. all three COT− exposition groups (Figure 4) . No significant differences in CSSA was found (P < 0.08) between these four groups ( Figure 5 ).
However, when a contrast analysis was performed, a significant effect was detected for a linear correlation. It shows a linear increase of CSSA across all groups with its highest in the COT+ group (P < 0.05).
No correlation between the level of cotinine corrected for dilution, using the CCR, and SpO 2 (P > 0,66), and CCR and CSSA (P > 0,659) were found.
| DISCUSSION
To our knowledge, this study has shown for the first time that in children hospitalized with RSV infection, SHS exposure assessed objectively is associated with lower oxygen saturation on admission and a worse overall clinical score. SHS exposure was measured using objective cotinine measurements, which is the major metabolite of tobacco smoke's main pollutant nicotine. There are various studies which have shown that subjectively detected SHS exposure has a negative impact on the clinical outcome in RSV bronchiolitis 1, 23 and other respiratory diseases 29 but to our knowledge, there is no such evidence in combination with the objective measurement of nicotine smoke exposure in children.
Questionnaire data on smoking behavior are at risk of reporting bias, 30 as patients'/caregivers' compliance and willingness to answer questions may vary. In our study, a small number of parents/caregivers was found who had denied SHS exposure, but whose children nevertheless had elevated urinary cotinine levels implying underreporting of exposure. Therefore, urinary cotinine can be used as an objective indicator for SHS. however, we were limited by our measurement method.
According to the analysis of the questionnaire used in this study, 40% of infants are exposed at a regular basis to tobacco smoke in their homes. One possible explanation why the number of cotinine containing urine samples was considerably lower than the number of the nicotine-exposed infants according to the reported high prevalence of exposure could be the time delay in urine sampling due to waiting times after arrival to the outpatient clinic. Additionally, we defined a maximum time span of 12 h for urine sampling in the study protocol, which may have been enough time for urinary cotinine to be eliminated and fall under the detection threshold. Another possible explanation may be that parents and other household members actually stop smoking around an obviously ill child with respiratory symptoms such as coughing and wheezing. In this case, children may not be detected as "recently exposed" to SHS, but under normal circumstances, when not acutely ill, they are routinely exposed to SHS in their daily life.
Another reason for questionnaire reported high-level SHS exposure and at the same time measured COT-negativity in the urine sample may be "diluting effect" of smoking in large apartments or smoking in designated rooms in absence of children, resulting in negative COT measurements in urine.
Beside this, in our study population, COT+ patients had statistically significant lower birthweight than COT− patients;
however, birthweight had no measurable effect on the relationship between the primary endpoint SpO 2 and cotinine exposure. This might be an effect of smoking in pregnancy, because heavily smoking mothers are likely to also smoke during pregnancy and this has been
shown to have an effect on birth weight. 31 One limitation of our study was that our questionnaire did not include the question of recent SHS within the last 24 h. It might be recommendable to add a question about recent SHS exposure in future questionnaires; however, when designing our questionnaire, we felt that asking about actual recent tobacco exposure in children with current respiratory illness was too suggestive.
Various potential sources of confounding need to be considered, when discussing severity of RSV bronchiolitis. We have excluded all children with any pre-existing lung disease including recurrent wheezing episodes and chronic lung disease of prematurity/ bronchopulmonary dysplasia as these are known risk factors for severe RSV infection. Children with clinically severe RSV bronchiolitis needing intensive care treatment were also not included into our study, because these children were transferred to intensive care unit directly.
Based on our exclusion policy, in our model prematurity, low birth weight (gestational age controlled), age adjusted weight on admission, as main risk factors for a more severe course of RSV bronchiolitis were not found to be a risk factor for worse outcome in our study population; in our model only urinary cotinine levels were found to be associated with our primary outcome parameter SpO 2 .
Smoking is more prevalent in lower socioeconomic classes where poverty is more prevalent and this could introduce a bias. More affluent parents might be more likely to be presenting to the hospital as they are less constrained by cost. However, this is unlikely to be the case in the reported study population-in Austria presentation to the hospital is free of charge for children, as well as transportation to the hospital when calling the ambulance. Therefore lower socioeconomic class is unlikely to be a major source of bias in this specific healthcare setting in Austria.
We found an association of urinary cotinine and more severe RSV infection; nevertheless, this does not necessarily prove causation. We measured cotinine as the major metabolite of nicotine and due to the numerous publications on the detrimental effects of nicotine on children's health, 6, 8, 29 nicotine is our main suspect. The association found may theoretically also be caused by another factor associated with tobacco smoking, for example another product related to smoking, which may actually be the reason for a more severe disease course.
However, an association of recent nicotine exposure with disease severity has been shown, this makes electronic cigarettes and other forms of nicotine replacement unlikely to be healthy and safe. Future research is needed to confirm this association.
The long-term effects of passive smoke exposure on patients' overall and respiratory health have been shown in various clinical trials. 1, 6, 7, 16, 20, 22, 23, 29 This study followed infants during the acute stage of the RSV LRTI disease and during their hospital stay. An association for an immediate effect on the clinical state was demonstrated.
| CONCLUSION
This study found an association between children with RSV LRTI and recent, objectively measured SHS exposure (measured by urinary cotinine levels) and lower oxygen saturation as well as a worse clinical condition than in children without recent SHS exposure. Future research is needed to confirm this association.
